Actively Recruiting
Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature
Led by Dong-A ST Co., Ltd. · Updated on 2023-04-12
2500
Participants Needed
1
Research Sites
564 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study evaluates long-term safety and effectiveness of Growtropin®-II treatment in children with short stature.
CONDITIONS
Official Title
Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children with short stature due to growth hormone deficiency, idiopathic short stature, Turner syndrome, or small for gestational age
- Children who have an official height record from at least 6 months prior
You will not qualify if you...
- Children with epiphyseal closure
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Yonsei University Health System, Severance Hospital
Seoul, Seodaemun-gu, South Korea, 03722
Actively Recruiting
Research Team
S
Sung
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here